Press Releases

Bloomberg News- AACC President Calls Genalyte’s Blood Diagnostic Tests “Game-Changing”

January 9, 2017

In a January 6th Bloomberg News story about investors making significant investments in blood testing startups, 2016 American Association of Clinical Chemistry President Patricia Jones said she was “impressed” with the results of Genalyte’s recent clinical study.


Genalyte Raises Additional $36 Million in Funding

November 21, 2016

Announcement of increased capital follows Genalyte’s presentation of clinical study data demonstrating the feasibility of whole blood testing in a near patient setting.


New Clinical Study Demonstrates Feasibility of Performing Multiplex ANA Testing on Whole Blood via Finger-Stick in Physician Office Near-Patient Setting

November 12, 2016

Genalyte’s Maverick™ Detection System illustrates potential to improve turnaround time for diagnosis.


First-Ever Clinical Results for Rapid, Near-Patient Diagnostics Platform to Be Presented At ACR/ARHP Annual Meeting

November 7, 2016

Genalyte to Present Two Scientific Posters on the Maverick™


Genalyte Appoints William A. Hagstrom to Board of Directors

June 16, 2016

Former CEO of Crescendo Bioscience Brings Three-Plus Decades of Experience in Healthcare Industry to San Diego-based Diagnostic Company.


Genalyte Founder & CEO Cary Gunn to Attend J.P. Morgan Healthcare Conference

December 28, 2015

CEO of Leading Diagnostics Innovator to Discuss Inflection Point for Industry and How New Technologies Can Transform Doctor, Patient Experience.


KCAS Bioanalytical & Biomarker Services and Genalyte Announce the Availability of GLP-compliant Assays on the Maverick™ Detection System

October 7, 2015

KCAS Bioanalytical & Biomarker Services, a small and large molecule Good Laboratory Practices (GLP)-compliant bioanalytical and biomarker Contract Research Organization (CRO), and Genalyte, Inc., a next-generation clinical and diagnostic life science detection company, announced today a collaborative agreement for KCAS to provide services using Genalyte’s multiplexed Maverick™ Detection System.

Genalyte Announces $44 Million Financing

August 18, 2015

Genalyte, Inc. announced today it has completed a Series C Financing round of $44 million, led by Khosla Ventures.  The company is redefining diagnostics with a testing platform and microchip technology that can be utilized in physician offices.  With the application of a single drop of blood to a silicon microchip, Genalyte’s Maverick Detection System can offer a complete panel of diagnostic test results in fifteen minutes.

Genalyte, Collaborators Gear Up for Phase Two of Tumor-associated Antigen Panel Development

February 3, 2015

Having completed the first phase of a $1 million National Cancer Institute grant to develop a panel of tumor-associated antibodies (TAAs) to help detect cancer and assess patient response to immune-modulating cancer drugs, Genalyte is now gearing up to manufacture a set of chips covering this panel to support the second phase of the project.

Biotech Firm Genalyte Announces Hiring of Former Defense Department Advisor Todd Ritter

February 2, 2015

Genalyte, Inc. today announced it has hired Todd Ritter, a former Defense Department Senior Medical Advisor and former Chief of Corporate Development at BioFire Diagnostics, Inc., as their new Vice President of Corporate Development. Ritter joins the company effective immediately.

Genalyte Completes First Phase of National Cancer Institute Grant Program

January 28, 2015

M.D. Anderson, Providence Cancer Center, and Wayne State University install new technology and testing platform for cancer screening. San Diego-based biotechnology company Genalyte announced today the completion of Phase 1 of its $1 million National Cancer Institute (NCI) grant, successfully developing and deploying a cancer biomarker panel and testing platform for screening.

A blog about Wordpress design, development , Software and inspiration